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Introduction
Throughout the second half of the twenty-first century, cardiovascular disease has
emerged as one of the preeminent focuses of American healthcare. Cardiovascular disease
(CVD) is the leading cause of death in the United States.1 In 2010, cardiovascular disease
accounted for 31.9% of the total deaths in the United States.1 While modern treatment methods
have produced a marked decline in CVD related mortalities, cardiovascular disease continues to
strain the American healthcare system. The American Heart Association estimates that 40.5% of
the population will exhibit some form of CVD by the year 2030.2 The upward spiral of CVD
prevalence has been accompanied by a corresponding increase in CVD-related healthcare costs.
In 2011, cardiovascular related healthcare expenditures constituted 17% of national healthcare
costs.2 In the decade between 2001 and 2011, the cost of CVD related healthcare rose by an
average annual rate of 6%.2
Clearly, the problem of cardiovascular disease in America must be addressed. In addition
to pharmacological methods, lifestyle interventions have been utilized in order to reduce
individual CVD risk. Lifestyle interventions have been focused around three major goals:
reducing the prevalence of smoking/tobacco use, reducing physical inactivity, and reducing the
prevalence of obesity.1 Over the last several decades, campaigns against smoking have been
effective at reducing its prevalence.1 However, the prevalence of obesity and physical inactivity
continue to increase within the United States.1 In order to evaluate the efficacy of risk-reducing
treatments, a working definition of cardiovascular disease and its characteristic risk factors must
first be established.

2

Cardiovascular disease includes any condition that involves the narrowing and/or
blockage of blood vessels. Narrowing of the blood vessels is a derivate of plaque accumulation
along the vessel walls, a condition termed atherosclerosis. Blockage of the vasculature in this
fashion can lead to a variety of life-threatening conditions such as heart attack, stroke, angina,
and heart failure.
A number of factors place an individual at an elevated risk for the development and/or
recurrence of cardiovascular disease. The primary risk factors associated with cardiovascular
disease are hypertension, dyslipidemia, insulin resistance, obesity (abdominal obesity has the
highest correlation), and diabetes mellitus.1,3 Hypertension and dyslipidemia are generally
considered more directly causal in their conveyance of risk for cardiovascular disease. The
expansion of arterial walls and the cardiac strain resulting from hypertension are directly
implicated in the onset of atherosclerosis. Likewise, the irregular lipid profiles associated with
dyslipidemia are fundamentally connected to the accumulation of arterial plaques. While still
primary risk factors, insulin resistance, obesity, and diabetes mellitus are, in comparison, less
mechanistically causal. Ultimately, CVD risk is assessed by a continuum of different risk
factors.3,4 Each variable conveys individual risk, but when these risk factors are seen in
conjunction, risk for the onset of cardiovascular disease is markedly increased. The multiplex of
these risk factors has come to be labeled the Metabolic Syndrome.3,4 Several organizations, such
as the World Health Organization and the National Cholesterol Education Program’s Adult
Treatment Panel III, have produced guidelines for the clinical diagnosis of these factors.
While not effective for the ascription of individualized CVD risk, demographic risk
statistics serve a valuable role in the epidemiological study of CVD. Age has long been
established as having a positive correlation with the CVD development. Gender can also
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increase risk for cardiovascular disease. Men are at a significantly higher risk for the
development of CVD than women of a similar age.1 Family history of cardiovascular disease
has been shown as an additional risk factor for CVD development. Race plays a significant role
in risk assessment for cardiovascular disease. African-American and Hispanic populations (as
well as other smaller racial groups) display higher rates of CVD development than the Caucasian
population.1 This racial incongruence is most likely due to the higher prevalence of
hypertension, obesity, and diabetes mellitus in those minority groups.1
Obesity
Obesity has long been implicated in the assessment of cardiovascular disease risk. The
onset of obesity has been linked with an increase in the prevalence of hypertension, insulin
resistance, dyslipidemia, and diabetes mellitus.5 In this capacity, obesity serves as a powerful
secondary risk factor for the development of cardiovascular disease. In addition to its role as a
secondary risk factor, obesity has also emerged as a powerful independent predictor for CVD.6
Given the elevated risk associated with the presence of multiple CVD risk factors, the reduction
of obesity is an ideal target for the reduction of cumulative risk for the onset of cardiovascular
disease.
While a variety of anthropomorphic measures are used to assess obesity, the Body Mass
Index is the most widely used of these various metrics. A Body Mass Index value between 25
and 29.9 kg/m2 classifies an individual as overweight, while a BMI value of 30 kg/m2 is
indicative of obesity.5 The prevalence of obesity has increased in parallel with the increase of
cardiovascular disease and diabetes mellitus.1 In 2010, 68.2% of the American population was
considered overweight or obese (34.6% of this population was considered obese).1
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Dietary Interventions
Dietary intervention provides an effective and efficient means by which to reduce an
individual’s risk for cardiovascular disease. Modulation of dietary intake can be effective for the
reduction of obesity as well as the treatment of several other cardiovascular risk factors.
Traditional diet programs have centered on portion control and caloric restriction.7 While the
evidence supporting energy restriction is incontrovertible, the importance of dietary
macronutrient content is now being explored.7
High-protein dietary interventions have emerged as one of several potentially viable
alternatives to traditional carbohydrate-centric dieting. These high-protein diet programs may
prove effective at treating obesity and adiposity as well as other CVD risk factors such as
elevated triacylglycerol levels, elevated cholesterol (total & LDL), reduced HDL cholesterol, and
poor glycemic control.
On a cellular level, the potential efficacy of a high-protein diet is logical. Protein is
generally processed and utilized for various biosynthetic purposes within the body.8 Dietary
protein in excess of that necessary for biosynthesis cannot be stored by the body.8 This is a
departure from what is seen in the metabolism of fats and carbohydrates. Fats and carbohydrates
may be readily converted and stored as triacylglycerol or glycogen molecules.8 However,
protein catabolism is significantly less stream-lined. Metabolically fated proteins must be
converted to high-energy metabolic intermediates. Intermediates such as pyruvate or αketoglutarate may then enter into an array of metabolic pathways (both anabolic and catabolic).8
From a systemic standpoint, this translates to a lower molecular energy yield and a
subsequently greater energy requirement for the utilization of protein as a fuel source. A variety
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of processes such as gluconeogenesis, peptide bond synthesis, and the generation of urea are
implicated in this increased energetic expenditure.9 Increases in energy expenditure associated
with macronutrient consumption are designated as the thermic effect of food.9 It can also be
viewed as the energy consumed by the processes of digestion.9 Generally, a thermic effect of 2035% of the energy consumed is associated with the ingestion of protein, whereas a thermic effect
of 5-14% is observed following the ingestion of carbohydrates.9 There is conflicting evidence
regarding the thermic effect of fat.9 While it is generally accepted that protein digestion induces
a greater thermic effect than carbohydrate digestion, it is unclear whether this difference is
clinically relevant.9 Further research must be conducted in order to fully understand the thermic
effect of macronutrient digestion and the role that this metabolic expenditure plays in weight
loss.
Increased satiety has also been correlated to elevated dietary protein intake. This
relationship is logical given the biosynthetic role of protein. Consequently, it has been proposed
that circulating amino acid concentrations serve as bio-indicators for satiety.9 While the current
literature generally supports a link between satiety and protein consumption, the mechanisms
underlying this effect have yet to be fully elucidated.9-11

The relatively complex physiological

processes associated with the mental perception of satiety make studies of this dietary aspect
difficult.9
Research on the thermogenic and satiety-inducing effects of dietary protein intake
provide sufficient evidence for the examination of a high-protein diet as an alternative to
traditional dietary interventions. High-protein diets may prove to be an effective means to
reduce obesity and/or other risk factors associated with cardiovascular disease. Numerous
studies have examined the potential health outcomes of a high-protein dietary intervention. This
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review will examine the current body of evidence associated with high-protein dietary
interventions and their role in the reduction of obesity as well as other CVD risk factors. A total
of 23 studies were included in this review. Of the 24 studies, 20 were randomized control trials,
2 were crossover trials, and the remaining 2 were meta-analyses/systematic reviews. Studies are
organized by experimental design, beginning with randomized control trials.

Study Outcomes

Randomized Control Trials
In the first randomized control trial (RCT), Brinkworth et al randomly assigned 66 (58)
obese, nondietetic adults with hyperinsulinemia to one of two dietary intervention groups.12 The
two intervention groups differed in respect to the protein content of their prescribed diets. The
high protein group maintained a daily diet with an approximate macronutrient distribution of
30% protein, 40% carbohydrate, and 30% fat (as a percentage of total energy intake). In
contrast, the standard protein group maintained a macronutrient distribution of 15%/55%/30%,
protein, carbohydrate, and fat, respectively.12 The two groups were subjected to 12 weeks of
energy restriction intervention and subsequently 4 weeks of energy balance intervention.
Following this initial 16 week period, subjects were asked to maintain a similar dietary pattern
for an additional 52 weeks.12 Exposure methods included daily dietary checklists and direct
supervision by a dieticians. Food Frequency Questionnaires were distributed every three months
throughout the 52 week follow-up period.12 At the conclusion of the 68 week study, both groups
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exhibited similar net weight loss (P˂0.01) due entirely to fat (P˂0.001).12 Lean body mass and
fasting glucose levels did not significantly change from baseline values.12 Both intervention
groups significantly increased HDL-C concentrations (P˂0.001) and decreased fasting insulin,
insulin resistance, sICAM-1, and CRP levels (P˂0.05).12 Dietary adherence greatly diminished
throughout the 52 week unsupervised follow-up period.
Claessens et al conducted an RCT examining the effects of ad libitum dieting on weight
maintenance and the reduction of metabolic risk factors. 60 (48) overweight or obese adults were
randomly assigned to either a high protein (≥25% total energy intake) or a high carbohydrate/low
protein group (C: ≥55% total energy intake).13 Both dietary interventions were fat reduced (30%
of total energy intake). The study consisted of 5-6 weeks of energy restriction followed by a 12
week ad libitum weight maintenance period. During the 5-6 week weight loss period, a very low
caloric (liquid) diet was implemented.13 Throughout the weight maintenance period, subjects
received group specific dietary supplements (HC: Maltodextrin, HP: whey/casein).13 Subjects in
the HP group experienced significantly better weight maintenance after the initial weight loss
(P˂0.02) than those in the LP/HC group.13 Fat mass reduction was also greater in the HP group
(P˂0.02).13 Following the weight maintenance period, triglyceride (P˂0.01) and glucagon
(P˂0.02) levels had increased significantly more in the HC group.13 Post-maintenance, glucose
concentrations rose more significantly in the HP group (P<0.02).13 TC, LDL-C, HDL-C, insulin,
HOMA, HbA1c, leptin, and adiponectin concentrations improvements did not significantly differ
between the two groups. Usage of whey vs. casein supplementation exhibited no significant
effect within the HP subject group.13 The usage of a VLCD as well as group specific dietary
supplementation may have affected the outcome of this study.
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Soenen et al (2010) also used dietary supplements to assess the effect of elevated protein
intake on body weight and body fat percentage.14 In this RCT, 24 health adults with a stable
body weight were randomly assigned to isoenergetic, ad libitum dietary interventions.14 The two
groups differed in the variety of dietary supplement subjects were provided.14 In the protein
supplemented group, a 2MJ milk-protein supplement was substituted for 2MJ of a subject’s
habitual diet.14 A 2MJ carbohydrate-fat supplement was substituted into the diets of subjects in
the control group.14 Both groups were instructed to ingest 200g of fruit and 300g of vegetables
per day.14 Dietary consultation was provided in order to ensure proper usage of the prescribed
dietary supplements.14 At the conclusion of the 3 month study, both groups were weight stable.14
In comparison to the control group, the protein supplemented group exhibited significant
reductions in body fat percentage, total fat mass, and waist circumference (P˂0.05, P˂0.05,
P˂0.01, respectively).14 Reductions in these measure were not significant in the CHO-fat
supplemented control group.14 Fat-free mass significantly increased in the protein supplemented
group (P˂0.01).14 However, the observed increase in FFM was marginally significant when
compared to FFM changes in the control group (P=0.05).14 Physical activity was unchanged for
both groups.
In a more recent study by Soenen et al (2012), energy restricted high protein and low
carbohydrate diets were examined for their potential effects on body weight reduction and body
weight maintenance.15 In this RCT, 139(132) overweight or obese adults were randomly
assigned to one of four dietary intervention groups.15 All diet groups participated in 12 month
energy restriction diet.15 During the first phase, caloric intake was restricted to 33% of each
subject’s estimated daily energy expenditure.15 After this initial 3 month phase, caloric intake
was increased to 67% of EDEE for the remainder of the interventions (9 months).15 Protein

9

intake constituted 1.2g of protein per kilogram of body weight in the high protein groups.15
Intake in the normal protein groups was 0.8g/kg.15 To account for the increase in caloric intake
experienced when transitioning from 33% to 67% of EDEE, relative macronutrient composition
was adjusted for all diet groups.15 Relative protein content of all diet groups was decreased in
order to maintain the prescribed absolute protein intake.15 All intervention groups varied in
respect to macronutrient composition. The four groups were as follows: high protein/low carb,
high protein/normal carb, normal protein/low carb, normal protein/normal carb (a full description
of macronutrient composition is listed in the appendix). Subjects were provided with diet
specific menus and attended counseling sessions based on diet group.15 24-H urinary analysis
was used to validate protein intake.15 At the conclusion of the 12 month study, dietary fat
content displayed no significant relationship to changes in body weight, fat mass, and fat-free
mass.15 Changes in FFM were significant for all groups, but did not significantly differ between
groups (P˂0.001).15 Reductions in body weight and fat mass were significantly greater in the
two HP groups than in the two NP groups (P˂0.001, respectively).15 Reductions in body weight
and fat mass did not significantly differ between HPNC & HPLC as well as NPNC &NPLC, but
were significant for all groups.15 There was no significant relationship between dietary
carbohydrate content and reductions in body weight or total fat mass.15 Metabolic parameters
decreased similarly for all diet groups (P˂0.01), with the exception of a significantly greater
reduction in diastolic blood pressure within the HPNC group (P˂0.01).15 Weight maintenance
as well as weight/fat mass reductions was dependent on the protein content of the diet.15
Due et al measured the effects of medium and high dietary protein content on body
weight. In this RCT, 50 overweight adults were randomly assigned to one of two dietary
interventions16. The two groups differed with respect to protein content. The high protein group

10

maintained protein intake at 25% of total energy intake. The medium protein group maintained
protein intake at 12% of total energy intake.16 Both diet groups were fat reduced (≤ 30% total
energy intake).16 During the first six months of the study, subjects collected all food from an onsite shop. Bar code scanning & regulated food distribution ensured dietary adherence during this
phase.16 After this initial 6 month phase, subjects participated in an additional 6-12 months of
dietary intervention.16 During this second phase, subjects maintained their diet independently.
Subjects attended dietary counselling throughout this second phase.16 Following the 12-18
month intervention, a 24 month follow-up was conducted.16 Subject attrition was greater than
50% for this 24 month follow-up. While macronutrient composition was controlled throughout
this study, energy intake was ad libitum.16 After 6 months, the HP group lost more weight
(P≤0.01) and exhibited a greater reduction in fat mass (P˂0.0001).16 After 12 months, weight
loss was not significantly different between the two groups. At 6 and 12 months, the HP group
exhibited a greater reduction in waist circumference (6/12 month: P˂0.01), waist/hip ratio (6/12
month: P˂0.01), and intra-abdominal fat mass (6 month: P˂0.01, 12 month: P˂0.05).16 After 6
months, free fatty acid (FFA) concentrations were significantly lower in the HP group
(P˂0.01).16 This effect diminished after 12 months.16 With the exception of FFA concentration
at 6 months, blood parameters did not differ significantly.16 Subject attrition (≥50%) at the 24
month follow-up diminished the statistical significance of data collected during that stage of the
RCT.16
Farnsworth et al conducted an RCT that examined a high-protein, energy-restricted diet
and its effect on body composition, glycemic control, and lipid concentrations.17 In this RCT,
66(57) overweight or obese adults were randomly assigned to two dietary intervention groups.17
The two groups differed in their respective protein content. In the high protein group, 27% of
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total energy intake was derived from protein, with 44% and 29% of total energy intake from
carbohydrates and fats respectively. A second, standard-protein group was prescribed a diet
consisting of a total energy intake of 16% protein, 57% carbohydrate, and 27% fat.17 Both
groups participated in a 12 week energy restriction intervention followed by a 4 week period of
energy balance.17 Throughout the study, subjects were given prescribed meal plans for their
respective interventions. In addition to these meal plans, subjects were supplied with key foods
that constituted 60% of their energy intake.17 To ensure dietary adherence, subjects completed
weighed daily food checklists and periodically (every 2 weeks) met with the same dietician.17 At
the conclusion of the study, weight loss, total fat mass reduction, glucose, insulin, insulin
resistance, LDL-C, HDL-C, and total cholesterol measurements were improved but not
significantly different between the intervention groups.17 Triacylglycerol concentration was
significantly more reduced in the HP group (P˂0.05).17 Following weight loss, glycemic
response decreased significantly more in the HP group (P˂0.05).17 For women in the HP group,
lean body mass was significantly better maintained (P=0.02).17 However, the effect on lean body
mass may have been due to the ratio of protein intake to body weight. Sex-dependent
differences in average body weight may have skewed this finding.
Flechtner-Mors et al studied the effects of protein-enriched meal replacements towards
inducing weight loss and improvements in metabolic syndrome criteria.18 In this RCT, 110
overweight or obese adults who presented at least 3 metabolic syndrome criteria were randomly
assigned to two dietary intervention groups.18 These groups differed with respect to dietary
protein content. Both diet groups participated in a 12 month energy restriction diet with a caloric
deficit of 500 kcal/day.18 Protein content was prescribed in proportion to body weight. The
relative ratio of grams of protein/kilogram body weight distinguished between high and normal
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protein diet groups.18 The high protein group was designated a 1.34g/kg protein to bodyweight
ratio, whereas the normal protein was designated a 0.8g/kg protein to bodyweight ratio.18 Both
diets were fat reduced (≤ 30% total energy intake).18 Augmentation of protein intake within the
high protein group was achieved by means of protein-enriched meal replacements or snacks.
Dietary adherence was controlled by means of dietary counseling and the submission of 3-day
food records.18 After the 12 month intervention, the HP group exhibited significantly greater
reductions in weight (P˂0.05) and total fat mass (P˂0.05) than the NP group.18 Reductions in
waist circumference (P˂0.05) and sagittal diameter (P˂0.01) were also more significant in the
HP group.18 CRP, HbA1C, serum triglycerides, and HDL-C concentrations significantly
improved in both groups, but more significantly in the HP group (P˂0.05, respectively).18
Fasting blood glucose and insulin levels decreased significantly in both groups, but no diet effect
was observed (P˂0.001).18 Both groups exhibited significant decreases in the presence of the
metabolic syndrome. At twelve months, 64.5% of subjects in the HP group and 34.8% of
subjects in the NP group no longer met three or more criteria for the metabolic syndrome.18
Reduction in the presence of metabolic syndrome criteria was more significant in the HP group
(P˂0.05).18 No adverse health effects were observed for either diet group.18
In another RCT, Krebs et al examined the efficacy and safety of a high protein, low
carbohydrate diet in obese adolescents.19 46(33) obese adolescents between the ages of 12 and
18 were randomly assigned to one of two dietary interventions.19 Both diet groups participated
in 12 weeks of dietary restriction with subsequent follow-ups at 13, 24, and 36 weeks (only
selected measurements were taken at 24 and 36 months).19 Dietary interventions differed with
respect to their macronutrient composition. The first group was prescribed a high protein, low
carbohydrate diet and the second was prescribed a low fat, high carbohydrate diet.
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Macronutrient composition, as a function of % total energy intake, was 32% P, 11%C, 29% F
and 21%P, 51%C, 29%F respectively.19 30 minutes/day of vigorous physical activity was
encouraged for both diet groups. Dietary education and guidance was provided throughout the
study. 3-day food records were used in order to gauge dietary adherence.19 After the
conclusions of the 13 week intervention, BMI-Z decreased significantly in both HPLC (P=0.04)
and LFHC groups (P=0.04), but the reduction was more significant in the HPLC group
(P=0.03).19 Maintenance of BMI-Z reduction was significant for both groups at 24 and 36
weeks, but no significant difference was seen between HPLC and LFHC groups.19 Reductions in
fat mass was significant for both groups, but there was no significant difference between HPLC
and LFHC groups.19 The HPLC group also displayed a marginally significant reduction in lean
body mass (P=0.05).19 A significant reduction in LBM was not observed in the LFHC group.
Both groups displayed significant decreases in TC and LDL-C, but no diet effect was observed.19
Both groups displayed reductions in triglyceride concentrations, but a significantly greater
reduction (3-fold greater) was observed in the HPLC group (P=0.0003 for HPLC reduction,
P=0.03 for difference between groups).19 Fasting glucose and 2-HR glucose levels did not
significantly improve for either group.19 Reduction in 2-HR insulin concentration was only
significant in the HPLC group (P=0.03).19 No serious adverse health effects were observed.
Lasker et al conducted an RCT comparing the efficacy of a moderate protein, moderate
carbohydrate and a high carbohydrate, low protein diet towards reducing CVD risk.20 In this
RCT, 87(50) obese adults were randomly assigned to two isocaloric dietary intervention
groups.20 Both intervention groups participated in a 4 month energy restriction diet with a
caloric deficit of 500 kcal/day.20 The two groups differed in respect to the macronutrient content
of their prescribed dietary programs.20 In the moderate protein, moderate carbohydrate group, a
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macronutrient distribution of 30% P, 40% C, and 30% F (% total energy intake) was
prescribed.20 In the high carbohydrate, low protein group, intake was distributed as 15%P,
55%C, and 30%F. Both diets were fat reduced (≤30% total energy intake).20 Subjects were
provided with daily menu plans as well as dietary education/recommendations.20 3-day food
records were collected throughout the study.20 At the conclusion of the 4 month study, body
weight, BMI, and fat mass had significantly decreased for both groups.20 While decreases in
BMI and body weight did not differ significantly differ between groups, the MPMC group
exhibited a significantly greater reduction in fat mass when compared to the HCLP group
(P=0.03).20 No effect of diet was observed for changes in fasting glucose and post-prandial
glucose response (P=0.19, 2hr P=0.59, respectively). No effect of diet was observed for
reductions in fasting insulin levels (P=0.31).20 However, the MPMC group displayed a
significantly greater reduction in 2-hour post-prandial insulin concentrations (P=0.03).20 A trend
for greater reduction of total cholesterol was observed for the HCLP group, but the difference
between groups was not significant (P=0.08).20 LDL-C concentration was reduced in the HCLP,
while an increase in this value was seen in the MPMC group (P=0.046).20 A reciprocal
relationship was seen for HDL-C concentrations. HDL-C increased significantly in the MPMC
group, while this value decreased for the HPLC group (P=0.045).20 TAG concentrations
decreased in both groups, but the decrease was more significant in the MPMC group (P=0.04).20
Layman et al conducted a similar 4 month study examining the effects of a moderate
protein diet on sustained weight loss and long-term changes in body composition and blood
lipids.21 In this RCT, 87(50) obese adults were randomly assigned to two isocaloric dietary
intervention groups.21 Both groups participated in a 4 month energy restriction intervention with
a caloric deficit of 500 kcal/day.21 Following this energy restriction phase, subjects participated
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in an 8 month weight maintenance diet phase. Intervention groups differed with respect to
dietary protein content. In the high-protein group, protein constituted 30% of the subjects’ total
energy intake.21 However, in the high-carbohydrate group, protein constituted only 15% of the
subject’s total energy intake.21 The diet groups displayed macronutrient distributions of
29%P/49%C/32%F and 18%P/59%C/26%F respectively.21 Dietary adherence was observed by
means of periodic 3-day food records.21 Subjects were provided food scales and given dietary a
series of dietary recommendations such as weighing all food items. At the completion of the 4
month energy restriction phase, both groups displayed significant decreases in body weight and
total fat mass.21 Weight loss did not differ between groups at 4 months (P=0.10).21 However,
the HP group had a significantly greater reduction in total fat mass (P˂0.04).21 Following the 8
month weight maintenance period, weight loss remained significant, but did not differ between
groups (P=0.18).21 Increased reduction in total fat mass for the HP group remained significant
after the weight maintenance period (P=0.06).21 After 4 months, the HC diet produced
significant reductions in TC and LDL-C (P˂0.01).21 Following the 8 month weight maintenance
period, reductions in TC and LDL-C were no longer significant for the HC group and a
significant difference was no longer observed between HC and HP groups.21 The HP group
produced significant improvements in TAG, HDL-C, and TAG: HDL-C at both 4 and 12 months
(P˂0.01).21
In an additional RCT, Leidy et al examined the effects of elevated protein intake on
weight loss and lean body mass in women.22 In their RCT, Leidy et al randomly assigned 54(46)
pre-obese and obese adult women to one of two dietary interventions.22 Both interventions
consisted of a 12 week energy restriction diet with a caloric deficit of 750 kcal/day.22
Intervention groups differed with respect to dietary protein content. In the high protein group,
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dietary protein constituted 30% of total daily energy intake.22 In contrast, protein intake in the
low protein group constituted only 18% of total energy intake.22 Both diet groups were provided
with 7 day meal plans for the duration of the study.22 In addition to these meal plans, each group
was provided portioned quantities of diet specific foods.22 In order to control for dietary
adherence, daily dietary intake checklists were periodically completed by study participants.22
At the conclusion of the study, significant decreases on body weight and fat mass were observed
for both groups, but differences between the two groups were not significant (no group effect:
P˂0.001).22 LBM preservation was significantly higher in the HP group (P˂0.05).22
Furthermore, LBM preservation was greater in pre-obese women than in obese subjects
(P˂0.005).22 This effect was independent of the diet effect on LBM preservation and the two
effects were additive. In the NP group, significant reductions were observed for fasting glucose,
total cholesterol, HDL-C, and LDL-C values (P˂0.001).22 The HP group displayed significant
reductions for total cholesterol, HDL-C, LDL-C, and triacylglycerol levels, with no significant
effect on fasting glucose (P˂0.001).22 In the previously described study by Farnsworth et al, a
similar LBM preservation effect was observed for female subjects.17
In a similar RCT with obese women, Noakes et al compared the effects of a high protein,
low carbohydrate diet and a high carbohydrate towards the reduction of body weight, body
composition, and CVD risk.23 119 (100) obese women were randomly assigned to one of two
isocaloric dietary intervention groups.23 Both groups participated in a 12 week energy restriction
diet with a caloric intake of ~5600kJ/day.23 Groups differed with respect to the macronutrient
content of their prescribed diets. In the high protein, low carbohydrate diet, macronutrient
distribution of total energy intake was divided as 31.3 ± 0.24% protein, 44.2 ± 0.42%
carbohydrate, and 22.1 ± 0.40% fat.23 In contrast, total energy intake was divided as 17.8 ±
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0.21% protein, 60.8 ± 0.58% carbohydrate, and 20.1 ± 0.52% fat in the high carbohydrate,
standard protein group.23 Food scales and selected food items were provided to all subjects.
Dietary counseling and recommendations were provided throughout the study. 3-day food
records were collected at two week intervals and daily food checklists were completed for the
duration of the study.23 At the conclusion of study, body weight, total fat mass, and midriff fat
mass decreased significantly for both groups, but there was no significant difference between the
diets (P=0.29, P=0.16, P=0.12, respectively).23 LDL-C, HDL-C, glucose, insulin, FFA, and CRP
decreased for both groups, but the difference between groups was not significant.23 The HPLC
group showed a greater decrease in TAG concentrations, but only a trend was observed
(P=0.07).23 Women with high serum TAG levels (˂1.5mmol/L) displayed a greater reduction in
fat mass (P=0.035) and TAG concentrations (P=0.023) with the HPLC diet.23
While the previous studies have compared high protein and carbohydrate-centric diets,
Luscombe-Marsh et al examined the efficacy of carbohydrate-restricted diets that differed in
protein and fat content.24 In this RCT, Luscombe-Marsh et al randomly assigned 73(57)
overweight or obese adults to two dietary intervention groups.24 Within the low fat, high protein
group, protein intake constituted 34% of total energy intake, while fat accounted for 29%.24 In
the high fat standard protein group, protein constituted only 18% of total energy intake, while fat
intake increased to 45%.24 Both groups participated in a 12 week energy restriction intervention
with a caloric deficit of 30% of each subject’s calculated caloric maintenance value.24 A 4 week
energy balance phase followed the initial energy restriction period.24 Subjects followed fixedmenu plans and were supplied intervention specific foods (60% of energy intake was
provided).24 Dietary adherence was controlled by means of periodically submitted dietary
intake checklists.24 Both LFHP and HFSP groups exhibited significant decreases in body
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weight, total fat mass, abdominal fat mass, and lean body mass.24 No effect of diet was observed
for these measures (P˂0.001, for all measures).24 However, male subjects lost 2% more of their
total body weight than did female subjects (time-by-sex int. P=0.03).24 Fasting glucose
concentrations did not significantly change from baseline in either group.24 Improvements were
seen in fasting insulin, HOMA insulin resistance and fasting FFA (P˂0.001).24 However, no
significant difference was seen between LFHP and HFSP for these values.24 Both groups
displayed significant reductions in total cholesterol, LDL-C, and triglycerol concentrations
(P˂0.001, P=0.005, P˂0.005, respectively).24 Both groups displayed significant increases in
HDL-C concentrations (P˂0.001).24 Blood lipid profiles significantly improved for both groups
but did not significantly differ between groups.24 No negative effects on bone turnover or renal
function were observed.24
Muzio et al conducted a study examining the effects of moderate dietary macronutrient
variation on reducing cardiovascular disease risk factors in patients with the metabolic
syndrome.25 In this RCT, 100 obese adults with the metabolic syndrome were randomly
assigned to two dietary intervention groups.25 The two groups differed with respect to the
prescribed macronutrient composition of their diet program. In the low-carb, high protein group,
total energy intake was divided as 19% protein, 48% carbohydrate, and 33% fat.25 Total energy
intake was divided as 13% protein, 65% carbohydrate, and 22% in the high carbohydrate, low
protein diet group.25 Both groups participated in a 5 month energy restricted intervention with a
caloric deficit based upon each individual’s estimated daily energy expenditure.25 Physical
activity was encouraged and group counseling was provided throughout the study.25 Dietary
adherence was measured via a 20-question adherence questionnaire. At the conclusion of the
study, body weight, BMI, waist girth, diastolic blood pressure, TC, blood glucose, insulin, and
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HOMA values decreased significantly in both groups.25 However, there was no group effect
observed for these risk factors.25 HDL-C did not significantly decrease from baseline in either
group. Systolic blood pressure (P˂0.001) and serum TAG levels (P˂0.05) decreased more
significantly in the HPLC group.25 Decreases in TAG levels were affected by weight loss
(P˂0.01) and the reduced carbohydrate content of the diet (P˂0.05).25 Only the HCLP group
displayed a significant decrease in LDL-C from baseline (P˂0.01). Both groups displayed a
reduction in the prevalence of the metabolic syndrome, but the difference between groups was
not significant. 25 While dietary adherence was well maintained throughout the study, the
relatively minimal variation in protein content may have affected some measured outcomes.
In a large RCT study, Sacks et al examined the efficacy of weight-loss diets that varied in
protein, carbohydrate, and fat composition.26 811(645) nondietetic, overweight/obese adults
were randomly assigned to one of four dietary intervention groups.26 Macronutrient composition
of the four diets was as follows (as a % of total energy intake): High protein/Low fat diet: 25%
protein, 55% carbohydrate, 20% fat, High protein/High fat diet: 25% P, 35% C, 40% F, Average
protein/Low fat: 15% P, 65% C, 20% F, Average Protein/High fat: 15% P, 45% C, 40%F.26 All
intervention groups participated in a 24 month energy restriction diet with a caloric deficit of 750
kcal/day.26 Measurements were taken at 6 month intervals. 5-day food records and nonconsecutive 24-hour dietary recalls were utilized to assess dietary intake of study participants.26
At the conclusion of the 2 year study, differences in dietary content of protein and fat had no
significant effect on weight loss (P=0.11, P=0.94).26 Carbohydrate level had no impact on
weight loss throughout the study.26 Change in waist circumference was significant for all
groups, but did not significantly differ between groups.26 The majority of weight loss occurred
during the first 6 months and did not significantly differ between intervention groups.26 After 2
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years, the two low fat diets decreased LDL-C more significantly than the two high fat groups
(P=0.001).26 Similarly, the highest-CHO diet decreased LDL-C more significantly than the
lowest-CHO group (P=0.01).26 The lowest-CHO group increased HDL-C concentrations more
significantly than did the highest-CHO group (P=0.02).26 All diets reduced blood pressure and
TAG levels significantly.26 All diets except the highest-CHO group displayed significant
reductions in fasting insulin concentrations.26 7% of study participants experienced severe
adverse health effects, but there was no significant difference in the prevalence of these effects
between diet groups.26 The efficacy of the four dietary interventions was not greatly impacted by
the respective macronutrient composition of each diet.26
In another RCT, Skov et al examined the effect of dietary protein and carbohydrate
content on obesity within an ad libitum treatment structure.27 In this study, 65 health, overweight
or obese adults were randomly assigned to one of three 6 month dietary intervention groups.27 A
control group was used in which macronutrient content was not regulated.27 The two modified
diets were fat reduced (≤ 30% TEI) and caloric intake was ad libitum.27 Groups differed with
respect to their protein and carbohydrate content. In the high protein group, total energy intake
was divided as 25% protein, 45% carbohydrate, and 30% fat.27 Total energy intake for the high
carbohydrate group was divided as 12% protein, 58% carbohydrate, and 30% fat.27 All food
items were provided via an on-site grocery store.27 All food purchases were recorded and
consultation was provided to assist in the selection of diet-appropriate food items.27 7-day food
records were collected throughout the study and alcohol consumption was regulated.27 Urinary
analysis was conducted to ensure dietary adherence.27 At the conclusion of the study, body
weight and composition had significantly improved for both groups (in comparison to the control
group), but the HP group experienced significantly greater reductions in weight, fat mass, and
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abdominal fat mass (P˂0.02, P˂0.0001, P˂0.0001, respectively).27 In comparison to the
control group, total cholesterol and HDL-C significantly decreased in both the HP and HC
groups.27 Plasma free fatty acids decreased in the HP group, but no change was observed for the
HC group (P˂0.05).27 At 3 months, plasma TAG’s had decreased for the HP group and
increased for the HC group (P=0.001).27 Differences in plasma TAG’s were not significant at 6
months.27
Tang et al conducted an RCT comparing the effects of normal and high protein diets
towards improving body composition and the incidence of the metabolic syndrome.28 In this
RCT, 55(43) overweight and obese men were randomly assigned to one of two isocaloric,
energy-restricted dietary interventions.28 The study was 12 weeks in duration and an energy
deficit of 750 kJ/day was maintained for both diet groups.28 Diets differed with respect to
macronutrient composition.28 Total energy intake for high protein and normal protein groups
was distributed as 25/50/25% and 15/60/25% protein, carbohydrate, fat, respectively.28 Dietary
intake was assessed by means of daily food checklists (completed weekly).28 Study participants
were provided dietary counseling for the duration of the study.28 At the conclusion of the 12
week study, reductions in body weight (P˂0.0001) and total fat mass (P˂0.0001) were
significant for both groups, but not significantly different between HP and NP groups.28 Lean
body mass was more significantly preserved in the HP group (P˂0.05).28 TC (P˂0.001), HDLC (P˂0.001), LDL-C (P˂0.001), TAG (P˂0.001), insulin (P˂0.05), glucose (P˂0.05), insulin
resistance (P˂0.05), and blood pressure (P˂0.001) measurements improved independent of
dietary protein content.28 Overweight subjects lost less lean body mass than obese subjects,
independent of dietary protein content.28 Obese subjects reduced TAG concentrations more
significantly than overweight subjects, independent of protein intake (P˂0.05).28
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In another RCT, Belbrajdic et al examined the weight reducing effects of two moderate
energy-restriction diets.29 In this study, 123 (76) overweight or obese men were randomly
assigned to one of two energy-restricted dietary intervention groups.29 Dietary interventions
were 12 weeks in duration with a daily caloric deficit of ~1650 kJ/day for both groups.29 Diets
differed with respect to macronutrient composition. In the high protein group, total energy
intake was divided as 33%, 37%, and 30% for protein, carbohydrate, and fat, respectively.29
Total energy was divided as 21%, 51%, 28% P/C/F in the high carbohydrate group.29 Subjects in
both groups were provided with 60% of their daily energy intake.29 3-day food records and daily
dietary checklists were completed throughout the duration of the study.29 At the conclusion of
the study, reductions in body weight (P˂0.0001) and total fat mass (P˂0.0001) were significant
for both groups, but did not significantly differ between groups.29 Reductions in abdominal fat
mass were more significant in the HP group (P˂0.02).29 Significant reductions in fasting
insulin, insulin sensitivity, adiponectin, and leptin concentrations were seen in both diets
(P˂0.0001, P˂0.0001, P˂0.001, P˂0.0001, respectively).29 No diet effect was observed for
these measures.
In the final RCT, Te Morenga et al compared the efficacy of two diets on reducing
weight in women at risk for the metabolic syndrome.30 In this RCT, 87(72) overweight or obese
women were assigned to one of two energy-restricted dietary intervention groups.30 Dietary
interventions were 8 weeks in duration with a caloric deficit of 2000-4000 kJ/day for both
groups.30 Diets differed with respect to macronutrient composition. In the high protein group,
total energy intake was divided as 28%, 40%, 29%, protein, carbohydrate, and fat, respectively.30
Total energy intake was divided as 22%, 51%, 23%, P/C/F for the high carbohydrate diet.30 In
addition to the designated macronutrient composition, the high carbohydrate group was
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instructed to consume greater than 35g of fiber per day.30 Subjects were provided group specific
food items and dietary recommendations were made for the duration of the study.30 3-day food
records were used to gauge dietary adherence.30 At the conclusion of the 8 week interventions,
both diets were effective at reducing waist circumference, total cholesterol, LDL-C, TAG’s,
fasting glucose and blood pressure (CI 95%, respectively).30 No diet effect was observed for
these measures.30 The HP group experienced greater reductions in body weight, total fat mass,
and diastolic blood pressure (P˂0.039, P˂0.029, P˂0.005, respectively).30 HDL-C increased in
both groups, but no effect of diet was observed (CI: 95%).30
Cross-over Studies
Two cross-over studies were analyzed in addition to the 19 previously discussed
randomized control trials. In the first crossover study, Appel et al examined the effect of
macronutrient intake on blood pressure and serum lipids.31 In this study, 164 healthy,
hypertensive adults participated in 18 weeks of dietary modulation.31 Subjects participated in
three 6 week feeding periods that differed with respect to macronutrient composition. Feeding
periods were separated by washout periods of 2-4 weeks.31 In the protein-rich feeding period,
total energy intake was divided as 25%, 48%, 27%, protein, carbohydrate, and fat, respectively.
During the carbohydrate rich feeding period, total energy intake was 15%, 58%, 33%, P/F/C,
respectively. In the final feeding period, a diet rich in unsaturated fat was consumed with a total
energy intake of 15%, 48%, 37%, P/F/C, respectively. All food was provided and prepared onsite. A 7-day menu cycle was utilized during all feeding periods. Weight was regulated for the
duration of the study and dietary compensations were made in order to keep weight within 2% of
baseline. At the conclusion of the 18 week study, the high protein diet was more effective than
the high carbohydrate diet at reducing systolic blood pressure, LDL-C, HDL-C, and TAG’s
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(P=0.02, P=0.01, P=0.02, P˂0.01, respectively). In comparison to the high carbohydrate group,
the high unsaturated fat group was more effective at reducing systolic blood pressure (P=0.05)
and TAG’s (P=0.02) and improved HDL-C more significantly (P=0.03). Substitution of protein
or unsaturated fat for carbohydrate intake lowered blood pressure and improved blood lipid
profiles.
In a second crossover trial, Jenkins et al examined the effects of a high-protein diet on
reducing serum lipids in hyperlipidemic adults.32 In this study, 20 hyperlipidemic adults
participated in two 1 month dietary interventions.32 The two intervention diets differed with
respect to macronutrient composition.32 In the high protein test group, total energy intake was
divided as 27.4%, 46.7%, and 25.6%, protein, carbohydrate, and fat, respectively.32 In the high
carbohydrate control group, total energy intake was constituted by 15.6%, 58.6%, and 25.5%,
protein, carbohydrate, and fat, respectively.32 Differences in dietary macronutrient intake were
accomplished by means of a macronutrient-controlled dietary supplement (a modified bread).32
At the conclusion of this crossover trial, no significant differences in total cholesterol or HDL-C
were observed between HP and control groups.32 TAG levels decreased more significantly in the
HP group than in the HC control group (P=0.003).32

Results & Conclusions

Results
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Of the 21 randomized control and crossover trials examined, 19 measured for changes in
body weight.12-30 In 7 of these 19 studies, high protein diet groups displayed significantly greater
reductions in body weight than did other study groups.13,15,16,18,19,27,30 The remaining 12 studies
did not exhibit an effect of diet on weight loss.12,14,17,20-26,28,29
Total blood cholesterol concentrations were measured in 19 of the 21 studies examined in
this review.12,13,15-28,30-32 A diet effect on total cholesterol levels was observed in a single study.
In the study by Layman et al (2009), total cholesterol reductions were significantly greater in the
high carbohydrate control group after four months of dietary intervention.21 However, no diet
effect was observed at the conclusion of the twelve month study.21 No other studies that
recorded total cholesterol values observed an effect of diet composition on this metric. Studies
by Brinkworth et al and Appel et al did not find significant reductions in total cholesterol for any
diet group.12,31
19 of the 21 studies examined in this review measured blood LDL-cholesterol
concentrations.12,13,15-28,30-32 Of the 19 studies that measured this value, five observed an effect of
diet composition.20,21,25,26,31 In the crossover trial by Appel et al (2001), the high protein diet
period displayed a significantly greater reduction in LDL-C values than was observed during
other diet periods.31 In contrast, 4 studies observed a significantly greater reduction of LDL-C
concentrations for the high carbohydrate control group than was seen in the high protein diet
group.20,21,25,26 In the RCT by Brinkworth et al, no significant reduction in LDL-C
concentrations was observed for either diet group.12 No effect of diet composition on HDL-C
concentrations was seen for 14 of the 19 studies that recorded this metric.12,13,15-19,22-24,27,28,30,32
19 of the 21 studies examined in this review measured blood HDL-cholesterol
concentrations.12,13,15-28,30-32 Of these 19 studies, five observed an effect of diet
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composition.18,20,21,26,31 In studies by Flechtner-Mors et al, Lasker et al, and Layman et al
significantly greater improvements in HDL-C concentrations were seen in the high protein group
than were seen in control groups.18,20,21 In studies by Sacks et al and Appel et al, HDL-C
improvements varied with carbohydrate content and unsaturated fat content, respectively.26,31 In
the RCT by Muzio et al, HDL-C values did not significantly change from baseline for any diet
group.25 No effect of diet composition on HDL-C concentrations was seen for 14 of the 19
studies that recorded this metric.11-13,15-17,19,22-25,27,28,32
Serum triglyceride concentrations were measured in 19 of the 21 studies examined in this
review.12,13,15-28,30-32 13 of the 19 studies that recorded this metric observed significantly greater
reductions in serum triglyceride concentrations within high protein diet groups.13,16-23,25,27,31,32 In
the study by Brinkworth et al, no significant change from baseline triglyceride concentrations
was seen for any diet group.12 No effect of diet composition on serum triglyceride concentration
was observed for 6 of the 19 studies that recorded this metric.12,15,24,26,28,30
Total fat mass was measured in 19 of the 21 studies examined in this review.12-30 Of
these 19 studies, 10 observed significantly greater reductions in total fat mass for high protein
diet groups in comparison to control diet groups.13-16,18-21,27,30 The remaining 9 studies that
recorded this metric did not show an effect of diet composition on fat mass reduction.12,17,2226,28,29

Abdominal fat mass was measured in 13 of the 21 studies examined in this review.13-18,2327,29,30

6 of the 13 studies that recorded this metric observed significantly greater reductions in

abdominal fat mass within high protein diet groups.13,14,16,18,27,29 The other 7 studies did not
display an effect of diet composition on reductions in abdominal fat mass.15,17,23-26,30
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Conclusions
Within the body of evidence examined in this review, a high protein diet did not
significantly differ from control diets with respect to the reduction of obesity and the
improvement of cardiovascular disease risk factors. High protein diets were more effective than
control diets at reducing body weight in 7 of the 21 studies examined.13,15,16,18,19,27,30 However,
the majority of studies did not show a significant difference in weight reduction between high
protein and control diets.
Changes in total cholesterol, LDL-C, and HDL-C concentrations did not significantly
differ between high protein and control diets for the majority of the studies that were reviewed.
High protein diet groups did not show significantly greater reductions in total cholesterol (in
comparison to control diets) in any of the 21 studies. Similarly, reductions in LDL-C
concentrations were only significantly greater for high protein diet groups in the study by Appel
et al.31 In 4 of the 21 studies, high protein diets were less effective at reducing LDL-C than
control diets.20,21,25,26 Most studies did not observe a significantly greater improvement of HDLC concentrations for high protein diet groups (only 3 groups observed such an effect).18,20,21
Despite these minor variations, a high protein diet did not produce significantly greater
improvements in total, LDL, or HDL cholesterol concentrations for the majority of the studies
examined in this review.
High protein diet groups displayed significantly greater reductions in serum triglyceride
concentrations in 13 of 21 studies.13,16-23,25,27,31,32 While far from conclusive, the findings of this
review suggest that, in comparison to control diets, a high protein diet may be effective at the
reduction of serum triglyceride levels.
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High protein diet groups displayed significantly greater reductions in total fat mass in 10
of the 21 studies examined within this review.13-16,18,19,27,30 These results are intriguing, but
conflicting. In comparison to control diets, high protein diets may be more effective at reducing
total fat mass, but further research must be done in order to confirm or deny this effect.
In comparison to control diet groups, high protein diet groups displayed significantly
greater reductions in abdominal fat mass in 6 of the 21 studies examined in this
review.13,14,16,18,27,29 However, this metric was only recorded in 13 of the 21 studies.13-18,23-27,29,30
A high protein diet may provide beneficial effects towards the reduction of abdominal fat mass,
but the body of evidence within this review is not large enough to confirm or deny such a claim.
The evidence presented within this review suggests that a high protein diet may be
effective at reducing body weight, serum triglyceride concentrations, and total/abdominal fat
mass. However, data regarding these metrics is conflicting. A larger, more inclusive analysis
may provide definitive conclusions as to the efficacy of a high protein diet towards reducing
obesity and improving cardiovascular disease risk factors.
Evidence-based Practice
As modern research continues to explore the potential benefits of a high protein diet,
physicians may begin to translate these findings into a variety of clinical applications. Once the
effects of a high protein diet are better understood, this diet may be incorporated into the
treatment of obesity, cardiovascular disease, and diabetes. Without definitive evidence
supporting the effects of a high protein diet, its usage as a treatment for specific health problems
may be limited.
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Ultimately, the effectiveness of any diet plan is affected by dietary adherence. Within the
context of individual adherence, high protein diets may prove to be more palatable for some
patients. The usage of a high protein diet for the treatment of non-compliant patients may have
some clinical utility.
Further Research
Further research must be done in order to fully elucidate the benefits of a high protein
diet. Within the context of this review, the measurement of glycemic control was not
standardized. The lack of uniform measurement made the glycemic effects of a high protein
difficult to effectively analyze. Research focused specifically on glycemic control would
produce a more wholistic representation of the efficacy of a high protein diet towards improving
cardiovascular and/or metabolic health.
Continued research on the satiety-inducing effects of protein consumption may also
prove beneficial. Elucidation of the mechanisms underlying satiety could open the door to a
number of nutritional and pharmacological therapies.
In addition to these avenues of research, the effects of a high protein diet on reducing
obesity as well as risk factors for cardiovascular disease must continue to be examined.

Appendices
High-Protein Summary Table
Author

N

Randomized Controlled Trials
Belobrajdic et al
123
29
2010
(76)

Age (yrs.)
mean/me
dian

Subject/BMI

Duration

Protein

Other
Diet(s)

Exposure
Measures

Measures/Outco
mes

µ 51±1
years

Overweight/O
bese Men
BMI µ
32.8±0.5

12 weeks
moderate

HP
(Isocaloric,
both energy
rest.)
P:33%
C:37%
F: 30%
(1651
kcal/day def)

HC
(Isocaloric,
both energy
rest.)
P: 21%
C: 51%
F: 28%
(1627
kcal/day def)

Dietary
consulation/gui
dance

No sig. diff.
between weight
loss and total fat
mass reduction
between groups.

energy
restriction
(7000kJ/d
ay)

60% of energy
intake supplied
3DFR
(weighed)
Daily Dietary
Checklist

HP group had
greater reduction
in abdominal fat
mass.
Improvements in
fasting insulin,
insulin sensitivity,
adiponectin and
leptin levels seen
for both groups,
no sig. diff.
between groups.
Changes in IGF
system derivative
of weight loss and
occured
independent of
dieatry protein
content.

1
Brinkworth et al
12
2004

66 (58)
43
comple
ted

20-65
years
µ 50.2
years

Obese,
nondietetic,
with
hyperinsuline
mia
BMI 27-43
BMI µ 34

68 weeks
total
12 wks.
Energy
restriction
(30%)
4 wks.
Energy
balance

HP (fat
reduced)
(% total
energy
intake)
P: 30%
C: 40%
F: 30%

SP (fat
reduced)
(% total
energy
intake)
P: 15%
C: 55%
F: 30%

Daily Diet
Checklist
Supervision by
dietician
(enegry
restriction/bala
nce)
Food
Frequency
Questionnaire
(every three
months in 12
month followup period)

52 weeks
additionals

Both groups: net
weight loss, incr.
HDL, dec. fasting
insulin, dec.
insulin resistance,
dec. sICAM-1,
and dec. CRP. (at
68 weeks)
No sig.
differences
between diets
among measured
values at 68
weeks.
No sig. decreases
in BP or glucose
Poor dietary
adherence in both
diet groups.

Claessens et al
13
2009

(60) 48

30-60
years
µ 45-46
years

Adults
Overweight/O
bese
BMI µ32-33

18 wk

HP (≥25%
energy)
Fat
Reduced
(30%
energy)

HC (≥55%
energy)
Fat
Reduced
(30%
energy)

VLCD (5-6 wk)
ad libitum
main. (12wk)
Dietary
Counseling
Protein/Carb.
Supplementati
on (by group)

HP diet group sig.
better weight
maintenance and
fat mass
reduction than HC
group
Triglyceride,
glucagon incr.
more sig. in HC
group
Fasting Glucose
incr. more sig. in
HP group

2
16

Due et all 2004

50

19-55
years
µ 39
years

BMI 26-34
µ 30-31

6 months
6-12
months
24 months

HP
(% total
energy
intake)
Protein 25%
Normal in fat
(<30% E)

MP
(% total
energy
intake)
Protein 12%
Normal in fat
(<30% E)

ad libitum
dieting
monitored,
experimental
grocery shop
dietary
counselling
7DFR

HP had greater
decrease in
weight at 6 mo.,
not sig. diff. at 12
months, greater
decrease FM
(6mo.)
HP had greater
loss of abdominal
fat mass and
higher proportion
of individuals with
>10 kg weight
loss.
HP greater
reduction in FFA
(6)

Farnsworth et al
17
2003

66 (57)

20-65
years
µ48-51

Obese/Overw
eight
Inclusion
factors:
fasting insulin
>12 mU/L
BMI 27-43
BMI µ 34

12 weeks
energy
restriction
(30%)
4 weeks
energy
balance

HP
(% total
energy
intake)
P: 27%
C: 44%
F: 29%

SP
(% total
energy
intake)
P: 16%
C: 57%
F: 27%

prescriptive
fixed-menu
plans
Daily food
checklists

Blood profile not
sig. diff. except
FFA
No sig. diff. in
weight loss, total
fat mass
reduction,
glucose, insulin,
insulin
resistance?, LDL,
HDL, and
cholesterol
HP: greater
decrease in
glucose AUC,
TAG
Women in HP
exp. Greater

3
preservation of
lean body mass

Flechtner-Mors et al
18
2010

110

25-70
years
µ ~50
(variance
groupgroup)

Obese/Overw
eight
(3 or more
MS criteria)
BMI: 27-45
BMI µ36

1 yr.

500 kcal/day
def.
HP:
1.34g/kg
body weight
Fat
Reduced
(30%
energy)

500 kcal/day
def.
NP: 0.8g/kg
body weight
Fat
Reduced
(30%
energy)

HP Group:
Proteinenriched meal
replacements

HP lost more
body weight and
fat mass than NP
group.

Dietary
Counseling
(Weekly Monthly)

Fat-free masssimilar reduction
across groups.

3-Day Food
Records
0,3,6,9,12
months

HP greater
reduction in
TAGs, CRP,
HbA1C, waist
circ., and sagital
circumference.
HP group
modestly higher
decline in MS
criteria (3 or
more) than NP
group.

4
19

Krebs et al 2010

46 (33)

12-18
years
µ 13-14
years

Obese
adolescents
≥175% ideal
body weight
BMI µ38-40

13 weeks
13,24,36
week
measurem
ents

HP-LC
P: 32%
C: 11%
F: 57%

LF-(HC,
relative)
P: 21%
C: 51%
F: 29%

3DFR
Physical
activity
encouraged
Dietary
education,
guidance
Subjective
assessments

BMI-Z sig.
reduced in both
groups, sig.
greater reduction
in HPLC group.
Maintenance of
BMI-Z decrease
was seen in both
groups, no sig.
diff. between
groups.
Loss of lean body
mass was not
spared in the
HPLC group.

Lasker et al 2008

20

87 (50)

40-56
years
µ 47
years

BW < 140 kg.
BMI >26

4 months
(500
kcal/day
deficit)

HP
(Isocaloric)
P: 30%
C: 40%
F: 30%

NP
(Isocaloric)
P: 15%
C: 55%
F: 30%

3DFR
Provided daily
menu plan,
dietary
education,
reccomendatio
ns

HPLC greater
reduction TAG's,
2-hour insulin.
No sig. diff. in
weight loss
between groups
HP-Greater
reduction of fat
mass, greater
decr. TAG,
greater incr. HDLC, greater decr. In
post-prandial INS
response
NP-greater
decrease LDL-C

5
21

Layman et al 2009

130

40-56
years
µ
45.4±1.2
years

Obese Adults
<140 Kg.
BMI >26
BMI µ
32.6±0.8

4 months
weight
loss (500
kcal/day
deficit)
8 month
weight
main.

HP (30% P)
P: 29%
C: ~49%
F: 32%

HC (15% P)
P: 18%
C: 59%
F: 26%

4+12 mo.
Values not
sig. diff.

4+12 mo.
Values not
sig. diff.

3DFR
Provided food
scales, recc. Of
weighing all
food, diet.
Meetings

No sig. diff. in
weight loss
between diet
groups.
HP group had
greater decrease
in fat mass, TAG,
TAG:HDL, and a
greater increase
in HDL-C than the
HC group at 4+12
months.
HC group had
greater decrease
in total choesterol
and LDL-C at 4
months, but not at
12 months.

Leidy et al 2007
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54 (46)

28-80
years
µ 46, 53
years

Women, ≥ 21
years, nondiabetic,
normal blood
profile, nonsmoker
BMI 26-37
BMI µ 30

12 weeks
(750
kcal/day
deficit)

HP
30% total
energy
intake from
protein

LP
18% total
energy
intake from
protein

Subgrouped
into pre-obese
and obese
pops.

HP group had
greater
preservation of
LBM.

7-day menus

Sig. decrease in
body weight and
fat mass for both
groups. Diff.
between groups
not sig.

daily dietary
intake checklist
log

Lipid-lipoprotein
profile and BP
improved and
kidney fxn.
Minimally
changed with
energy restriction,

6
independently of
protein intake.

Luscombe-Marsh et
24
al 2005

73 (57)

20-65
years
µ 48-53
years

Overweight/O
bese Adults
BMI 27-40
BMI µ 33.8

12 weeks
energy
restriction
(30%)
4 weeks
energy
balance

LF-HP
P: 34 ±
0.8%
F: 29 ± 1%

HF-SP
P: 18 ±
0.3%
F: 45 ± 0.6%

Fixed-menu
plans
Provided food
Daily dietary
intake
checklists

Both diet groups
showed
decreases in :
weight, fat mass,
total chosterol,
LDL, TAG, fasting
insulin, insulin
resistance, FFA.
HDL also
increased.
Effects were not
sig. diff. between
groups
No sig. change in
bone turnover,
inflammation, or
renal fxn.
LF-HP test meal
had greater
satiety effect
No sig. effect on
fasting plasma
glucose for either
group.
Decrease in REE

7
not sig. diff.
between diet
groups.
Decrease in TEF
with weight loss
was smaller in
LF-HP group.
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Muzio et al 2007

100

>18 years
µ 53
years

obese,
metabolic
syndrome
BMI ≥ 30
BMI µ 37

5 months
(500
kcal/day
individuali
zed caloric
deficit)

LC-HP (high
monounsatu
rated fat)
P: 19%
C: 48%
F: 33%

HC-LP
P: 13%
C: 65%
F: 22%

Monlthy, group
sessions
Adherence
questionnaire

No sig. diff. in
HDL from
baseline
HC-LP:sig. decr.
In LDL cholesterol
LC-HP: greater
decr. In the prev.
of hypertension
and
hypertriacylglycer
olemia, TG conc.,
and systolic BP
Sig. decrease, but
no group diff. in
weight, BMI, waist
girth, cholesterol,
glucose, insulin,
HOMA

8
23

Noakes et al 2005

119
(100)

20-65
years
µ 49
years

Obese
Women
BMI 27-40
BMI µ 32

12 weeks
energy
restriction
(30%)
4 weeks
energy
balance

HP
(Isocaloric, µ
5310 kJ)
P: 31.3 ±
0.24%
C: 44.2 ±
0.42%
F: 22.1 ±
0.40%

SP
(Isocaloric,
µ 5219 kJ)
P: 17.8 ±
0.21%
C: 60.8 ±
0.58%
F: 20.1 ±
0.52%

Dietary
Guidelines,
Reccomendati
ons, quasi ad
libitum

No sig. diff. in
weight loss or fat
loss (among
completers)
between diet
groups.

Provided food
Dietary
Counselling
Daily Food
Checklist
3-d weighed
food record
every 2 week
interval.

No sig. diff.
between groups
for decr. observed
with LDL, HDL,
glucose, insulin,
FFA, and Creactive proteins.
HP greater
reduction in TAG
conc.
Subjects with
elevated TAG
conc.'s showed
greater decrease
in midriff fat, total
fat mass and TAG
levels. (Greater
decrease in HP
group)

9
26

Sacks et al 2009

811
(645)

30-70
years
µ 50-52
years

Overweight,
Obese,
nondietetic,
compliant
BMI 25-40
BMI µ 33

24 months
(750
kcal/day
deficit)

HP
(P/F/C)
25/20/55%
25/40/35%

NP
(P/F/C)
15/20/65%
15/40/45%

5DFR
24-Hour Recall
Group/individu
al counselling
Questionnaire

25+15% Protein
diet groups lost
similar weight.
40+20% Fat diet
groups lost similar
weight.
Carbohydrate
level had no
effect on weight
loss.
No sig.
diff.between
groups for change
in waist circ.,
decr. In BP, and
decr. In TG lvls.
All diets except
Highest-CHO
decreased fasting
insulin, decrease
was larger with
HP diet than NP
diet.
2 LF + HighestCHO diet more
effective at
decreasing LDLC.
Lowest CHO diet
increased HDL-C
more than
Highest CHO diet.
Reduced-calorie
diets result in
clinically

10
meaningful weight
loss regardless of
which
macronutrients
they emphasize.
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Skov et al 1999

65

18-56
years
µ 37-39

Healthy,
overweight
and obese
BMI ≥ 25
µ 30

6 months

HP (fat
reduced)
(% total
energy
intake)
P: 25%
C: 45%
F: 30%

LP (fat
reduced)
(% total
energy
intake)
P: 12%
C: 58%
F: 30%

ad libitum
dieting
recorded/regul
ated grocery
purchase w/
consultation
7DFR (alcohol
consumption)
Urine analysis
(N excretion)

HP group had
greater decrease
in weight, fat
mass, and
abdominal fat
mass.
HP sig.
decreased TAG
(at 3mo, not 6
mo) and free fatty
acids.
No sig. diff. in
total cholesterol
or HDL.

11
14

Soenen 2010

24

20-42
years
µ 31
years

Adults (good
health, stable
body weight)

3 mo.

HP:
Isoenergetic
Incr. via
protein
supp. (52g)
(200g
fruit/300g
veg)

Control:
Isoenergetic
Carb/Fat
Supp.
(200g
fruit/300g
veg)

ad libitum
dieting
consultation to
ensure proper
supp. Intake

Body Fat %
decreased in HP
group vs. control.
Fat-free mass
incr. in HP group,
fat mass dec. in
HP. (Control
unchanged).
Physical Activity
Unchanged

15

Soenen 2012

139
(132)

23-71
years
µ 50±12
years

Overweight/O
bese
BMI 27-60
µ 37±6

12
months:
total
3 months:
33%
energy
req.
9 months:
67: energy
req.

HP
P/C/F
3 mo. (33%)
HPLC:
60/5/35%
HPNC:
60/35/5%
9 mo. (67%)
HPLC:
30/25/45%
HPNC:
30/45/25%

NP
P/C/F
3 mo. (33%)
NPLC:
30/5/65%
NPNC:
30/35/35%
9 mo. (67%)
NPLC:15/25
/60%
NPNC:
15/45/40%

Macro
composition
adjusted for
absolute
protein intake
24 hour urinary
analysis to
ensure protein
intake
Grouporganized
program
Prescribed,
unique menus
for each group

Weight Stable
HP had sig. effect
on weight loss vs.
NP at 3+12
months. (similar
relationship not
seen with LC and
NC groups)
Relationships
between changes
in BW, FM, FFM
and % energy
intake dietary fat
not significant.
HPNC vs. all
other diets
reduced diastolic
BP more.
All groups, sig.
decr. In BW and
FM at 3 months,
12 months.
Weight loss +

12
weight-main.
depend on protein
component of
dietary
interventions but
not on carb.
component.
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Tang et al 2013

(55) 43

≥ 21
years
µ 43
years

Men
(Obese/Over
weight
groups)
BMI µ 31.5
(25-39.9)

1+12 wk

HP:
25/50/25
(F/C/P)

NP:
25/60/15
(F/C/P)

Dietary
Counseling
Daily Food
Checklist
(turned in
weekly)

Both groups
comparable body
weight, fat loss.
HP group lost
less lean body
mass than NP
group.
No sig. diff. in
other factors
(HDL-C,
cholesterol,
glucose, etc..)
Obese: greater
reductions in TAG
Overweight:
better
preservation of
LBM

13
Te Morenga et al
2011

87 (72)

18-65
years
µ 40-43
years

Overweight/O
bese Women
BMI ≥ 27
BMI µ 33-34

8 weeks
(20004000
kJ/day
energy
deficit,
total
energy
never
below
5500
kJ/day)

HP
P:28(5)%
C:40(6)%
F: 29(5)%
Av. Values
(SD)

Hfib (>35g) HC
P: 22(3)%
C: 51(6)%
F: 23(6)%
Av. Values
(SD)

3DFR
Dietary
reccomendatio
ns, some
provided food
items (changed
for diet group)

Both diets were
effective at
reducing body
weight, total body
fat, and waist
circumference.
HP lost more
body weight+total
body fat and
reduced diastolic
BP to a greater
degree.
Both diets were
effective at
reducing
total+LDL
cholesterol,
TAG's, fasting
glucose, and BP.
No sig. diff.
between diet
groups.

Metaanalyses/Reviews
Santesso et al 2012

74
studies

> 18
years
µ 45
years

Adults
At least 80%,
no medically
indicated
dietary
restrictions
BMI µ 33
(22-43)

≥ 28 days

High Protein

Low Protein
(5%
difference
between HP
and LP, in
terms of %
of total
energy
intake from
protein)

N/A

Pooled
standardized
effect sizes
(small-moderate)
favored HP diets
for: Weight Loss,
BMI, Waist circ.,
BP (D+S), HDL,
insulin, and
TAGs.
No sig. effects:
total chol., LDL,
C-reactive

14
proteins, HbA1c,
glucose, and
surrogates for
bone/kidney
health.

Wycherley et al 2012

24
studies

≥18 years

Adults

≥4 weeks
µ 12.1 ±
9.3 weeks

1063
indiv.

Crossover Trials
31
Appel et al 2005

164

>30 years
µ 54
years

Healthy
adults,
Hypertensive
BMI: 30

3-period, 6
weeks/fee
ding
period

HP
(Macro %)
P:µ
30.5±2.4%
C:µ
41.6±3.5%
F:µ
27.8±3.2%

SP
(Macro %)
P:µ
17.5±1.5%
C:µ
56.0±3.3%
F:µ
25.1±3.1%

N/A

Protein-rich
P: 25%
C: 48%
F: 27%

C-rich
P/C/F
15/58/33%

7-day menu
cycle

Unsat. Fat
Rich
P/C/F
15/48/37%

Multivariable
meta-regresion
showed no
signficant dose
response with
higher protein
intake.
HP: greater
reduction in
weight, FM, and
TAGs, lower
reduction of FFM
No sig. diff. in
total chol, LDL,
HDL, BP, insulin,
or glucose.

All food
provided and
prepared onsite.

BP, LDL chol.
Decr. From
baseline in all
groups.
When compared
with CHO diet,
HP diet showed
greater decr.
Systolic BP, LDLC, and TAG's.
When compared
to CHO, Unsat.
Fat diet showed
larger decreased

15
in systolic BP,
decr. TAG's, incr.
HDL (No diff.
between LDL
changes)

32

Jenkins et al 2001

20

35-71
years
µ
55.6±1.9
years

Hyperlipidemi
c
Men/Women
BMI 20.3-31.2
BMI µ 26±0.7

1
month/diet

HP
(% total
energy
intake)
P:
27.4±0.3%
C:
46.7±0.4%
F:
25.6±0.4%

Control
(% total
energy
intake)
P:
15.6±0.3%
C:
58.6±0.5%
F:
25.5±0.5%

Macronutrientcontrolled
dietary
supplement
(bread, control
and HP)

No sig. diff. in
total cholesterol,
HDL-C.
HP diet: greater
decr. In TAG, uric
acid, and
creatinine, high
conc. Of urea,
and higher 24H
urinary urea
output.
Lower amount of
LDL oxidation in
HP group.

16

High-Protein Study Outcome(s)
Crossover
Trials

P= protein more sig.
result
0= Data Not Recorded
(=)No sig. diff. between
groups
Others = other group
more sig. result
NS=No significant
change for any group

# Studies
Recorded

Metaanalyses/Re
v.

Soenen 2012

Tang et al 2013

Te Morenga et al 2011

P

=

P

=

P

=

=

0

=

=

=

NS

=

=

=

0

=

=

=

=

P

P

=

=

=

=

0

=

=

P
P
P

P
P
0

P
P
0

P
P

P
=
0

=
=
=

P
=
=

P
=
=

=
=
=

P
P
P

0
P
P

=
P
=

=
=
0

P
USF
R
P/U
SFR
0
0

=

P

=
H
C
L
C

=

=

=
H
C
N
S

=

=

=
H
C

0

=
P
=

0

Wycherley et al 2012

Santesso et al 2012

16

32

P
=
=

Jenkins et al 2001

P
P
P

0

31

P
P
P

Appel et al 2005

=

28

=

15

=

=

14

=

Soenen 2010

=

27

=

Skov et al 1999

=

26

=

Sacks et al 2009

=

23

=

25

=

22

=

21

=

20

P

19

P

17

=

13

12

=
N
S
=
0

P

30

Noakes et al 2005

24

=

18

Muzio et al 2007

0
=
P

Luscombe-Marsh et al 2005

TAG's
Adiposity
Abdominal Adiposity

Leidy et al 2007

0

=

P

Layman et al 2009

HDL-C

=

Lasker et al 2008

0

=

Krebs et al 2010

LDL-C

=

Flechtner-Mors et al 2010

0

=
HC
(4)
HC
(4)

Farnsworth et al 2003

Total Cholesterol

=
N
S
N
S

Due et all 2004

=

Claessens et al 2009

Outcomes
Weight-Loss

Brinkworth et al 2004

Belobrajdic et al 2010

29

Randomized Controlled Trials

Total Study
Outcome

7P

19

P

P

19

=

=

19

=

=

=

1C
4HC,
1P
3P,
2O

19

P

=

P
0
0

13P
10P
6P

19
19
13

P
=
P

P
P
0
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